Twenty-three states and the District of Columbia on Tuesday accused the Trump administration of illegally terminating about $11 billion in public health funding, causing layoffs and "chaos" in public health agencies across the country law360.com/articles/23186…

State attorneys general are expected to ramp up their False Claims Act enforcement amid the federal push to cut spending and potentially shift some Medicaid costs onto states law360.com/healthcare-aut…

A Rhode Island federal judge on Thursday barred the Trump administration from moving forward for now with the termination of billions of dollars in grants supporting state public health programs law360.com/articles/23201…

The life sciences industry escaped much of the immediate impact of President Donald Trump's market-shaking tariff order, but the relief may not last long. A look at how drugmakers may respond: law360.com/healthcare-aut…

A look at the options and limitations facing Dr. Oz if he chooses to crack down on upcoding in privately run Medicare plans: law360.com/healthcare-aut…

A federal prosecutor's letter to a medical journal skeptically asking about its commitment to nonpartisan debate is an unusual intrusion into editorial decision-making and may interfere with First Amendment rights, free speech experts say law360.com/healthcare-aut…

A massive overhaul underway at the U.S. Department of Health and Human Services will wipe out the roles filled by more than 100 attorneys and other staff at regional offices in six states, damaging efforts to combat elder abuse and neglect, HHS staff say law360.com/healthcare-aut…

The Trump administration's decision to boot pharmaceutical employees off FDA advisory panels won't do much to address conflicts of interest. But experts say other steps could help insulate the agency from undue influence law360.com/healthcare-aut…

Even with a shrinking workforce, the FDA's plan to expand surprise inspections of overseas drug manufacturing plants is a legitimate enforcement threat that should be taken seriously, experts say. A look at some of the potential challenges, consequences: law360.com/healthcare-aut…

A year after Washington’s landmark health privacy law took effect, attorneys are bracing for the first judicial interpretation defining the law's reach and closely watching a proposed class action law360.com/healthcare-aut…

An unusual new law in Utah zeroes in on the growing world of mental health chatbots, establishing privacy and advertising guardrails for the intimate conversations a patient might share with a virtual therapist law360.com/healthcare-aut…

The FDA's speedy adoption of Elsa, its new artificial intelligence tool, is raising questions about how it was trained and the safeguards against AI-generated hallucinations law360.com/healthcare-aut…

Despite staff cuts and leadership changes, the FDA has launched a burst of enforcement activity targeting prescription drug promotion, singling out a "sex pill" post on Instagram and an exhibit panel touting a diuretic law360.com/healthcare-aut…

My rare story in front of the paywall: A look at criminal prosecutions in the post-Roe era law360.com/articles/23586…

Here's the deal. We're not going to remain silent while our management blunders through poorly conceived AI experiments. We are proud journalists and we'll protect ourselves. niemanlab.org/2025/07/law360…

An Oregon woman died in the cold after leaving her memory care unit in 2023. Now state lawmakers are moving to strengthen oversight of long-term care facilities that serve older adults, including those with dementia law360.com/healthcare-aut…

The first batch of rejection letters published as part of the FDA’s new transparency effort didn’t shake up the industry. But future releases could spur litigation and influence drug-development strategies, depending on how far the agency is willing to go law360.com/healthcare-aut…

Vaccine law experts say Robert F. Kennedy Jr.’s warning to doctors and hospitals about the possibility of losing vaccine liability protections is a "red herring," misleading and conflates different parts of the law law360.com/healthcare-aut…

The Trump administration highlighted direct-to-consumer prescription drug ads in its MAHA report today and followed up tonight with plans for a rule that it says would require the disclosure of more safety info in ads law360.com/articles/23855…